Back to search

Article

Optimized AAV capsids for diseases of the basal ganglia show robust potency and distribution in adult nonhuman primates

2024-05-05

Abstract excerpt

Huntington’s disease and other disorders of the basal ganglia create challenges for biomolecule-based medicines given the poor accessibility of these deep brain structures following intracerebral or intravascular delivery. Additionally, for adeno-associated viruses (AAVs) intravascular delivery exposes peripheral tissues to the vast majority of the therapy, increasing the risk of immune responses and the quantity...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05e24cde-876d-50ab-94db-e820a004c003
DOI
10.1101/2024.05.02.592211
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimized AAV capsids for diseases of the basal ganglia show robust potency and distribution in adult nonhuman primatesDOI 10.1101/2024.05.02.592211
Select a neighboring publication to make it the new centre.